Results 101 to 110 of about 4,572 (202)

Comorbilidad y riesgo cardiovascular en sujetos con primer diagnóstico de hipercolesterolemia

Revista Española de Salud Pública, 2011
Fundamento, Para un adecuado abordaje de los sujetos en los que se identifica por primera vez la presencia de hipercolesterolemia es importante considerar simultáneamente tanto sus factores de riesgo cardiovascular como la presencia de otras enfermedades.
Ignacio Párraga Martínez, José María del Campo del Campo, Rafael Muñoz Sánchez-Villacañas, Alejandro Villena Ferrer, Susana Morena Rayo, Natividad González Felipe, Jesús López-Torres Hidalgo   +6 more
doaj  

Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report. [PDF]

GE Port J Gastroenterol, 2023
Sequeira C, Coelho M, Costa Santos I, Ramos Lopes S, Mangualde J, Oliveira AP.   +5 more
europepmc   +1 more source

Targeted Screening of Familial Hypercholesterolemia in 11 Small Brazilian Cities: An Effective Approach to Detect Clusters of Affected Individuals. [PDF]

Arq Bras Cardiol, 2022
Izar MCO, Fonseca FAH.
europepmc   +1 more source

Myocardial Infarction and Traditional Cardiovascular Risk Factors in Older Patients in Primary Care. [PDF]

Rev Bras Enferm
Bertelli EVM, Ribeiro GJS, Barros FRB, Oliveira JV, Marinho ML, Pinto AA.   +5 more
europepmc   +1 more source

Detecting Familial Hypercholesterolemia in Adolescents: Universal Screening is Key. [PDF]

Arq Bras Cardiol
Cesena FY.
europepmc   +1 more source

[Abdominal aortic aneurysm prevalence study in Primary Care]. [PDF]

Aten Primaria
Suárez Gil MDC, Santana Rocamora P, Miranda Cortina R, Suárez Perdomo S, Hernández Benítez P, Sierra Farinelli C.   +5 more
europepmc   +1 more source

Alopecia Universalis after Treatment with Simvastatin and Ezetimibe: Affects on Family. [PDF]

Arq Bras Cardiol, 2022
Ozyurtlu F, Cetin N.
europepmc   +1 more source

Hipercolesterolemia familiar heterocigota en manejo

, 2017
Resumen Introducción: la hipercolesterolemia familiar representa un factor de riesgo sustancial para padecer enfermedad coronaria prematura, arterial periférica y valvular. Se han descrito dos formas según su alteración genética y cigocidad, así como tres mutaciones genéticas asociadas.
Duque, Mauricio, Gaviria, María C., González, Juanita, Gallo, Juan E.   +3 more
openaire   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveys. [PDF]

Bull World Health Organ
Sulola MA, Sibai AM, Damasceno A, Issanov A, Sarria-Santamera A, Orazumbekova B, Norov B, Bicaba B, Houehanou C, Guwatudde D, Kagaruki GB, Gathecha G, Jorgensen JA, Mwangi KJ, Agoudavi K, Sturua L, Mayige MT, Gurung M, Hwalla N, Lunet N, Mwalim O, McClure RW, Quesnel-Crooks S, Bahendeka S, Atun R, Bärnighausen T, Davies J, Flood D, Geldsetzer P, Jaacks L, Manne-Goehler J, Theilmann M, Vollmer S, Marcus ME.   +33 more
europepmc   +1 more source